Indeed, NF-κB expression has been widely observed in diverse tumor types, in response to hyperactivation of Akt [44], and protects cells against cell death through activation of genes such as Bcl-2 and Bcl-xL [45]. The gene discussed is NFKB1; the disease is neoplasm.